2.29 (-%)
As of Dec 12, 2024
Source:
Nkarta, Inc is a clinical-stage biopharmaceutical company advancing the development of allogeneic, off-the-shelf engineered natural killer cell therapies for the treatment of patients with autoimmune diseases or hematologic malignancies.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (925) 407-1049 |
Industry | manufacturing |
CEO | Paul J. Hastings |
Website | www.nkartatx.com |